ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias | Dana-Farber Cancer Institute / Loren Walensky, MD, PhD | Innovation Grants | 2023 | Massachusetts |
Desmoplastic Small Round Cell Tumors: Investigation of its Pathogenesis and Development of Novel Therapies | Memorial Sloan-Kettering Cancer Center / Andrea Ventura, MD, PhD | Innovation Grants | 2023 | New York |
A Genomics Driven Pluripotent Stem Cell Model of Infant Lymphoblastic Leukemia | Children's Mercy Hospital Kansas City / Meagan Vacek, DO | Catalyst Grants | 2023 | Missouri |
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies | Baylor College of Medicine / Masataka Suzuki, PhD | Innovation Grants | 2023 | Texas |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma | Duke University / Zachary Reitman, MD/PhD | 'A' Award Grants | 2023 | North Carolina |
Pre-Targeted Radioimmunotherapy for Desmoplastic Small Round Cell Tumors | Memorial Sloan-Kettering Cancer Center / Madelyn Espinosa-Cotton, PhD | Young Investigator Grants | 2023 | New York |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network | Boston Children’s Hospital / Richard Voit, MD/PhD | Young Investigator Grants | 2023 | Massachusetts |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors | Baylor College of Medicine / Andras Heczey, MD | R Accelerated Award Grants | 2023 | Texas |
CLL-1 CAR-T cells with or without trametinib for the treatment of JMML | The Regents of the University of California San Francisco / Elliot Stieglitz, MD | R Accelerated Award Grants | 2023 | California |
Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase | City of Hope National Medical Center / Ling Li, PhD | R Accelerated Award Grants | 2023 | California |